Remove .Net Remove Biotechnology Remove Software
article thumbnail

Adaptive Biotechnologies revenue rises 57% in 2021 to $154.3M

GeekWire

Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Net loss for 2021 came in at $207.3 million in the fourth quarter, up 26%, with a net loss of $61.4 Adaptive moved into its new headquarters in September. Co-founders Harlan (left) and Chad Robins on the new plaza. million in 2020.

article thumbnail

Biotech companies fuel IPO boom in Washington state over the past year

GeekWire

In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped lead a recent IPO boom in the state of Washington, accounting for eight of 11 firms joining the public markets via a traditional IPO over the past year. based biotech company went public. Absci Photo).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tech Moves: Meta leader for Pacific NW steps down; Phase Genomics adds to C-suite

GeekWire

Susan Wyrick of Sana Biotechnology. LinkedIn Photo) — Susan Wyrick , senior vice president of finance and accounting at Sana Biotechnology , is serving as acting chief financial officer, treasurer, and principal accounting officer for the publicly traded company. — There’s new leadership at CTL , a Beaverton, Ore.,

article thumbnail

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

GeekWire

Formerly known as M3 Biotechnology, the company is led by Dr. Leen Kawas , a 35-year-old CEO who will be the first woman to guide a company to an initial public offering in Washington state in more than two decades. In its IPO paperwork, Athira reported a net loss of $5.2 billion in the largest software IPO ever.

article thumbnail

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

GeekWire

The company, previously known as M3 Biotechnology, is led by Dr. Leen Kawas , a 35-year-old entrepreneur originally from Jordan. In its IPO paperwork, Athira reports a net loss of $5.2 It would be the first Seattle biotech to go public since Adaptive Biotechnologies IPO’d last year. million in 2019, and a loss of $3.8

article thumbnail

Accolade sets terms for IPO, aims to raise up to $211M in Seattle’s first public offering this year

GeekWire

million net loss and $132.5 million net loss and $94.8 Singh previously co-founded travel expense software giant Concur and brought on fellow Concur co-founder Mike Hilton as chief product officer at Accolade, which originally launched back in 2007. It plans to trade on the Nasdaq exchange under the ticker ACCD. Vancouver, Wash.-based

.Net 91
article thumbnail

Seattle startup Banzai to go public via SPAC and acquire marketing tech company Hyros

GeekWire

Banzai , a Seattle marketing software startup, announced Thursday that it will go public after it agreed to merge with a special-purpose acquisition company. Seattle businesses including Porch, Nautilus Biotechnology, Rover and Leafly have all gone public via SPAC within the last two years. Banzai CEO Joe Levy. Banzai Photo).

Company 99